NASDAQ:IDYA - IDEAYA Biosciences Price Target & Analyst Ratings

$9.48
-0.31 (-3.17 %)
(As of 09/17/2019 04:00 PM ET)
Today's Range
$9.21
Now: $9.48
$10.03
50-Day Range
$6.0350
MA: $6.89
$8.75
52-Week Range
$5.42
Now: $9.48
$16.90
Volume2,814 shs
Average Volume15,985 shs
Market Capitalization$184.67 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

IDEAYA Biosciences (NASDAQ:IDYA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for IDEAYA Biosciences in the last 12 months. Their average twelve-month price target is $19.75, suggesting that the stock has a possible upside of 108.33%. The high price target for IDYA is $30.00 and the low price target for IDYA is $14.00. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 2.752.672.67N/A
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $19.75$16.3333$16.3333N/A
Price Target Upside: 108.33% upside50.96% upside50.96% upsideN/A

IDEAYA Biosciences (NASDAQ:IDYA) Consensus Price Target History

IDEAYA Biosciences (NASDAQ:IDYA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/9/2019Robert W. BairdInitiated CoverageOutperform$30.00High
6/17/2019Jefferies Financial GroupInitiated CoverageBuy$14.00Low
6/17/2019CitigroupInitiated CoverageBuy$20.00Low
6/17/2019JPMorgan Chase & Co.Initiated CoverageNeutral$15.00Low
(Data available from 9/17/2017 forward)
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Featured Article: What is Call Option Volume?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel